Growth Hormone Deficiency (GHD)

A New Association in Peters' Plus Syndrome (PPS)

Kuk Wha Lee, Phillip Lee

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We report a case of a girl with clinical features of Peters' Plus Syndrome (PPS) (association of anterior eye chamber defects; peculiar facies; cleft lip/palate; brachymelia; developmental delay; growth retardation) and documented growth hormone deficiency (height -3.5 SDS at chronological age 5 years 8 months; low growth factors; bone age delay; growth velocity 4.4 cm/year (<3rd centile); and peak growth hormone levels of 1.7 and 4.7 ng/ml by clonidine and insulin provocative testing, respectively). Treatment with recombinant human growth hormone (0.3 mg/kg/week) resulted in a dramatic increase in growth velocity, increasing the height from -3.5 to -1.5 SDS over 2.3 years of therapy, indicative of an excellent response. Growth retardation is a known association in PPS: a condition that includes other midline facial defects. This case supports a role for GHD in the pathogenesis of the short stature observed in these children; demonstrates the efficacy of GH treatment; and further reinforces the relationship of pituitary anomalies with common congenital defects.

Original languageEnglish (US)
Pages (from-to)388-391
Number of pages4
JournalAmerican Journal of Medical Genetics
Volume124 A
Issue number4
StatePublished - Feb 1 2004
Externally publishedYes

Fingerprint

Growth Hormone
Growth
Human Growth Hormone
Cleft Lip
Clonidine
Cleft Palate
Anterior Chamber
Intercellular Signaling Peptides and Proteins
Insulin
Bone and Bones
Krause-Kivlin syndrome
Therapeutics

Keywords

  • Growth hormone deficiency
  • Peters' plus syndrome

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Growth Hormone Deficiency (GHD) : A New Association in Peters' Plus Syndrome (PPS). / Lee, Kuk Wha; Lee, Phillip.

In: American Journal of Medical Genetics, Vol. 124 A, No. 4, 01.02.2004, p. 388-391.

Research output: Contribution to journalArticle

@article{39d77b812c8748f5a8c15a8afe14e847,
title = "Growth Hormone Deficiency (GHD): A New Association in Peters' Plus Syndrome (PPS)",
abstract = "We report a case of a girl with clinical features of Peters' Plus Syndrome (PPS) (association of anterior eye chamber defects; peculiar facies; cleft lip/palate; brachymelia; developmental delay; growth retardation) and documented growth hormone deficiency (height -3.5 SDS at chronological age 5 years 8 months; low growth factors; bone age delay; growth velocity 4.4 cm/year (<3rd centile); and peak growth hormone levels of 1.7 and 4.7 ng/ml by clonidine and insulin provocative testing, respectively). Treatment with recombinant human growth hormone (0.3 mg/kg/week) resulted in a dramatic increase in growth velocity, increasing the height from -3.5 to -1.5 SDS over 2.3 years of therapy, indicative of an excellent response. Growth retardation is a known association in PPS: a condition that includes other midline facial defects. This case supports a role for GHD in the pathogenesis of the short stature observed in these children; demonstrates the efficacy of GH treatment; and further reinforces the relationship of pituitary anomalies with common congenital defects.",
keywords = "Growth hormone deficiency, Peters' plus syndrome",
author = "Lee, {Kuk Wha} and Phillip Lee",
year = "2004",
month = "2",
day = "1",
language = "English (US)",
volume = "124 A",
pages = "388--391",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Growth Hormone Deficiency (GHD)

T2 - A New Association in Peters' Plus Syndrome (PPS)

AU - Lee, Kuk Wha

AU - Lee, Phillip

PY - 2004/2/1

Y1 - 2004/2/1

N2 - We report a case of a girl with clinical features of Peters' Plus Syndrome (PPS) (association of anterior eye chamber defects; peculiar facies; cleft lip/palate; brachymelia; developmental delay; growth retardation) and documented growth hormone deficiency (height -3.5 SDS at chronological age 5 years 8 months; low growth factors; bone age delay; growth velocity 4.4 cm/year (<3rd centile); and peak growth hormone levels of 1.7 and 4.7 ng/ml by clonidine and insulin provocative testing, respectively). Treatment with recombinant human growth hormone (0.3 mg/kg/week) resulted in a dramatic increase in growth velocity, increasing the height from -3.5 to -1.5 SDS over 2.3 years of therapy, indicative of an excellent response. Growth retardation is a known association in PPS: a condition that includes other midline facial defects. This case supports a role for GHD in the pathogenesis of the short stature observed in these children; demonstrates the efficacy of GH treatment; and further reinforces the relationship of pituitary anomalies with common congenital defects.

AB - We report a case of a girl with clinical features of Peters' Plus Syndrome (PPS) (association of anterior eye chamber defects; peculiar facies; cleft lip/palate; brachymelia; developmental delay; growth retardation) and documented growth hormone deficiency (height -3.5 SDS at chronological age 5 years 8 months; low growth factors; bone age delay; growth velocity 4.4 cm/year (<3rd centile); and peak growth hormone levels of 1.7 and 4.7 ng/ml by clonidine and insulin provocative testing, respectively). Treatment with recombinant human growth hormone (0.3 mg/kg/week) resulted in a dramatic increase in growth velocity, increasing the height from -3.5 to -1.5 SDS over 2.3 years of therapy, indicative of an excellent response. Growth retardation is a known association in PPS: a condition that includes other midline facial defects. This case supports a role for GHD in the pathogenesis of the short stature observed in these children; demonstrates the efficacy of GH treatment; and further reinforces the relationship of pituitary anomalies with common congenital defects.

KW - Growth hormone deficiency

KW - Peters' plus syndrome

UR - http://www.scopus.com/inward/record.url?scp=0942301440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0942301440&partnerID=8YFLogxK

M3 - Article

VL - 124 A

SP - 388

EP - 391

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 4

ER -